Skip to content

Microwaves Ablation of Varicose Veins

Microwaves Ablation of Varicose Veins

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05508581
Enrollment
20
Registered
2022-08-19
Start date
2022-11-01
Completion date
2023-12-15
Last updated
2024-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose Veins

Brief summary

Lower-limb varicose veins (VVs) are the most common of vascular diseases and affect up to one-third of the population, severely affecting the quality of life (QoL) of patients. In past decades, traditional surgical ligation and stripping were the gold standard therapy for patients with VVs; however, traditional methods have demonstrated high complication and recurrence rates. Thus, the practices are moving toward minimally invasive alternatives.

Detailed description

Lower-limb varicose veins (VVs) are the most common of vascular diseases and affect up to one-third of the population, severely affecting the quality of life (QoL) of patients. In past decades, traditional surgical ligation and stripping were the gold standard therapy for patients with VVs; however, traditional methods have demonstrated high complication and recurrence rates. Thus, the practices are moving toward minimally invasive alternatives. Endo venous thermal ablation, such as radiofrequency ablation and endo venous laser ablation (EVLA), has become the recommended first-line treatment for VVs worldwide. These endo venous procedures provide a quicker recovery time and improved QoL and produce fewer complications than traditional surgery .Endo venous microwaves ablation is a minimally invasive procedure in treatment of V.V, investigators confirmed that endo venous microwave ablation (EMA) was an effective new technique for the treatment of VVs. On previous trials confirmed that the endo venous microwave ablation procedure demonstrated a shorter procedure time, lower complication, and local recurrence than the endo venous laser ablation procedure. The aim of the study was to determine whether endo venous microwave ablation of varicose vein was associated with better effectiveness and less complications and evaluate the outcome of patients who underwent endo venous microwave ablation (EMA).

Interventions

PROCEDUREmicrowaves ablation of varicose veins

Microwave ablation is an endovenous treatment. This is a similar treatment approach as laser ablation and radiofrequency ablation. Endovenous means that the treatment device is inside the vein during treatment.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Age between 18 and 60 years, either sex, elective admission 2. primary symptomatic VVS (CEAP,C3-C6) 3. Recurrent Varicose Veins after surgery 4. Greater saphenous vein diameter up to 3 cm 5. Greater saphenous vein with variable depth even with depth less than 6mm 6. Greater saphenous vein with tortuosity 7. Diabetic patient with risk of wound infection after surgery 8. Patient with hostile groin 9. Availability of patients for all follow-up visits

Exclusion criteria

1. secondary Varicose Veins 2. Acute thrombosis near the Saphenous-femoral junction 3. Recanalized Greater saphenous vein 4. pregnancy

Design outcomes

Primary

MeasureTime frameDescription
1.Number of Participants with Lack of flow or closed great saphenous vein6 monthsComplete ablation of varicose veins done or if any residual remind
2.Operation timeIntraoperativeThe time of the whole procedure

Secondary

MeasureTime frameDescription
1. Number of Participants with recurrence varicose vein varicose veins reappear again after the operation12 monthReopening of the Varicose veins
2. Number of Participants with adverse effect of the procedure12 monthsThrombophlebitis,Infection or blood loss

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026